Answers are grounded in this paper and cite their sources.
Neuropsychiatric symptoms of dementia can be challenging to patient and carers, and affect the majority of people with dementia at some stage. Symptoms including agitation, aggression, and psychosis may respond to non‐pharmacological therapy. If pharmacotherapy is required the family and carers should be informed and involved in defining treatment goals and monitoring progress. The best current evidence is for atypical antipsychotics with two randomised controlled trials supporting the use of risperidone. However, there are concerns about an increased risk of stroke and death from atypical antipsychotics. Other drug classes have less supportive evidence for efficacy, but may be appropriate for specific symptoms. In all cases, attempts should be made to minimise the dose of the drug and cease it entirely after a time.
No takes yet. Share an insight, caveat, or question.
Michael C. Woodward (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: